Creative Planning
CTSO icon

Creative Planning’s Cytosorbents Corp CTSO Stock Holding History

Creative Planning’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-16,400
Closed -$1K – 1979
2018
Q3 		$1K Sell
16,400
-3,600
-18% -$45.1K ﹤0.01% 2051
2018
Q2 		$12K Buy
+20,000
New +$189K ﹤0.01% 1941

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Creative Planning's CTSO Position: Q1 2026 in Review

Creative Planning held its Cytosorbents Corp (CTSO) position steady in Q1 2026 at 21,295 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4066.

Creative Planning first reported a position in CTSO in Q4 2015 and has held it in 39 quarters since. The position peaked at $617K in Q2 2018. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

  • Creative Planning held 21,295 shares of Cytosorbents Corp worth $12.1K as of Q1 2026.
  • Creative Planning left its Cytosorbents Corp share count unchanged in Q1 2026.
  • Cytosorbents Corp made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #4066 holding.
  • Creative Planning first reported a position in Cytosorbents Corp in Q4 2015 and has held it in 39 quarters since.
  • Creative Planning's Cytosorbents Corp position peaked at $617K in Q2 2018.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.